{"transactions":[{"id":706539,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-07-17T20:15:40.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":115283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the consummation of the Merger, each reported restricted stock unit (\"RSU\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger."}],"balance_after":0,"derivative":{"expiration_date":"2028-11-20","underlying":"Common Stock","underlying_shares":115283},"source":{"system":"sec-edgar","filing":"0001161697-26-000173","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169726000173/form4.xml","form_type":"4"}},{"id":706538,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-07-17T20:15:40.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":40013,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the consummation of the Merger, each reported restricted stock unit (\"RSU\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger."}],"balance_after":0,"derivative":{"expiration_date":"2027-11-21","underlying":"Common Stock","underlying_shares":40013},"source":{"system":"sec-edgar","filing":"0001161697-26-000173","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169726000173/form4.xml","form_type":"4"}},{"id":706537,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-07-17T20:15:40.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":126316,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"kind","element":"transactionCoding","label":"F4","text":"In connection with the consummation of the Merger, each reported restricted stock unit (\"RSU\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share, multiplied by (y) the number of shares subject to such RSU."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger."}],"balance_after":0,"derivative":{"expiration_date":"2029-01-01","underlying":"Common Stock","underlying_shares":126316},"source":{"system":"sec-edgar","filing":"0001161697-26-000173","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169726000173/form4.xml","form_type":"4"}},{"id":706536,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to purchase common stock","published_at":"2026-07-17T20:15:40.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":381948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger."}],"balance_after":0,"derivative":{"exercise_price":22.77,"expiration_date":"2032-11-20","underlying":"Common Stock","underlying_shares":381948},"source":{"system":"sec-edgar","filing":"0001161697-26-000173","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169726000173/form4.xml","form_type":"4"}},{"id":706535,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to purchase common stock","published_at":"2026-07-17T20:15:40.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":491160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger."}],"balance_after":0,"derivative":{"exercise_price":21.12,"expiration_date":"2031-11-21","underlying":"Common Stock","underlying_shares":491160},"source":{"system":"sec-edgar","filing":"0001161697-26-000173","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169726000173/form4.xml","form_type":"4"}},{"id":706534,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to purchase common stock","published_at":"2026-07-17T20:15:40.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1365319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Each Option or RSU, as applicable, vested in full in connection with the consummation of the Merger."}],"balance_after":0,"derivative":{"exercise_price":13.3,"expiration_date":"2031-01-01","underlying":"Common Stock","underlying_shares":1365319},"source":{"system":"sec-edgar","filing":"0001161697-26-000173","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169726000173/form4.xml","form_type":"4"}},{"id":706533,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to purchase common stock","published_at":"2026-07-17T20:15:40.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":18.59,"expiration_date":"2029-12-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001161697-26-000173","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169726000173/form4.xml","form_type":"4"}},{"id":706532,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to purchase common stock","published_at":"2026-07-17T20:15:40.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.07,"expiration_date":"2028-12-28","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001161697-26-000173","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169726000173/form4.xml","form_type":"4"}},{"id":706531,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to purchase common stock","published_at":"2026-07-17T20:15:40.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":3.42,"expiration_date":"2027-12-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001161697-26-000173","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169726000173/form4.xml","form_type":"4"}},{"id":706530,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to purchase common stock","published_at":"2026-07-17T20:15:40.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the consummation of the Merger, each reported stock option (\"Option\") was cancelled and converted into the right to receive a cash payment (without interest, and less applicable tax withholdings and other authorized deductions) equal to the product of (x) the excess of $31.50 per share over the per-share price of such Option, multiplied by (y) the total number of shares subject to such Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each Option was fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.64,"expiration_date":"2026-12-02","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001161697-26-000173","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169726000173/form4.xml","form_type":"4"}},{"id":706529,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2026-07-17T20:15:40.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":271266,"price":31.5,"value":8544879.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported securities were disposed of in connection with the consummation of the acquisition of the Issuer by Angelini Pharma S.p.A. (the \"Merger\")"}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001161697-26-000173","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169726000173/form4.xml","form_type":"4"}},{"id":945888,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2026-01-06T22:00:30.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":42105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Derivative securities vest in equal tranches, 1/5th on January 1, 2025, 1/5th on January 1, 2026, 1/5th on January 1, 2027, 1/5th on January 1, 2028, and 1/5th on January 1, 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on January 5, 2026."}],"balance_after":2618539,"derivative":{"underlying":"Common Stock","underlying_shares":42105},"source":{"system":"sec-edgar","filing":"0001161697-26-000021","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169726000021/form4.xml","form_type":"4"}},{"id":945887,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2026-01-06T22:00:30.000Z","date":"2026-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":10577,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock."}],"balance_after":271266,"source":{"system":"sec-edgar","filing":"0001161697-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169726000021/form4.xml","form_type":"4"}},{"id":945886,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2026-01-06T22:00:30.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":42105,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":281843,"source":{"system":"sec-edgar","filing":"0001161697-26-000021","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169726000021/form4.xml","form_type":"4"}},{"id":957036,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-12-30T22:00:16.000Z","date":"2025-12-29","kind":"exercise","planned":false,"acquired":false,"shares":1334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Derivative securities vested in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024, and 1/3rd on December 27, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The final tranche of shares was delivered on December 29, 2025."}],"balance_after":2660644,"derivative":{"underlying":"Common Stock","underlying_shares":1334},"source":{"system":"sec-edgar","filing":"0001161697-25-000488","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000488/form4.xml","form_type":"4"}},{"id":957035,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-12-30T22:00:16.000Z","date":"2025-12-29","kind":"tax_withholding","planned":false,"acquired":false,"shares":524,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock."}],"balance_after":239738,"source":{"system":"sec-edgar","filing":"0001161697-25-000488","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000488/form4.xml","form_type":"4"}},{"id":957034,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-12-30T22:00:16.000Z","date":"2025-12-29","kind":"exercise","planned":false,"acquired":true,"shares":1334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":240262,"source":{"system":"sec-edgar","filing":"0001161697-25-000488","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000488/form4.xml","form_type":"4"}},{"id":989747,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-11-25T01:08:25.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":false,"shares":20006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Derivative securities vest in equal tranches, 1/3rd on November 21, 2025, 1/3rd on November 21, 2026, and 1/3rd on November 21, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on November 21, 2025."}],"balance_after":2661978,"derivative":{"underlying":"Common Stock","underlying_shares":20006},"source":{"system":"sec-edgar","filing":"0001161697-25-000413","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000413/form4.xml","form_type":"4"}},{"id":989746,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-11-25T01:08:25.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":115283,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027 and 1/3rd on November 20, 2028."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."}],"balance_after":2681984,"derivative":{"underlying":"Common Stock","underlying_shares":115283},"source":{"system":"sec-edgar","filing":"0001161697-25-000413","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000413/form4.xml","form_type":"4"}},{"id":989745,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to purchase common stock","published_at":"2025-11-25T01:08:25.000Z","date":"2025-11-20","kind":"grant","planned":false,"acquired":true,"shares":381948,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Derivative securities vest in equal tranches, 1/3rd on November 20, 2026, 1/3rd on November 20, 2027 and 1/3rd on November 20, 2028."}],"balance_after":2546695,"derivative":{"exercise_price":22.77,"expiration_date":"2032-11-20","underlying":"Common Stock","underlying_shares":381948},"source":{"system":"sec-edgar","filing":"0001161697-25-000413","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000413/form4.xml","form_type":"4"}},{"id":989744,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-11-25T01:08:25.000Z","date":"2025-11-21","kind":"tax_withholding","planned":false,"acquired":false,"shares":7872,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted common stock."}],"balance_after":238928,"source":{"system":"sec-edgar","filing":"0001161697-25-000413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000413/form4.xml","form_type":"4"}},{"id":989743,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-11-25T01:08:25.000Z","date":"2025-11-21","kind":"exercise","planned":false,"acquired":true,"shares":20006,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":246800,"source":{"system":"sec-edgar","filing":"0001161697-25-000413","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000413/form4.xml","form_type":"4"}},{"id":1053477,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to purchase common stock","published_at":"2025-08-28T21:00:04.000Z","date":"2025-08-26","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vested in three annual tranches beginning on December 19, 2019."}],"balance_after":2184753,"derivative":{"exercise_price":2.24,"expiration_date":"2025-12-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001161697-25-000300","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000300/form4.xml","form_type":"4"}},{"id":1053476,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock, par value $0.001 per share","published_at":"2025-08-28T21:00:04.000Z","date":"2025-08-26","kind":"sale","planned":false,"acquired":false,"shares":22970,"price":20.62,"value":473641.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were sold on the open market to fund the exercise price and tax withholding due from Mr. Daly on the exercise of the 50,000 stock options reported on Table II."}],"balance_after":226794,"source":{"system":"sec-edgar","filing":"0001161697-25-000300","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000300/form4.xml","form_type":"4"}},{"id":1053475,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock, par value $0.001 per share","published_at":"2025-08-28T21:00:04.000Z","date":"2025-08-26","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":2.24,"value":112000.0,"ownership":{"direct":true},"balance_after":249764,"source":{"system":"sec-edgar","filing":"0001161697-25-000300","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000300/form4.xml","form_type":"4"}},{"id":1124420,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock, par value $0.001 per share","published_at":"2025-06-03T21:00:35.000Z","date":"2025-05-30","kind":"sale","planned":false,"acquired":true,"shares":70000,"price":24.86,"value":1740200.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents a weighted average price for the shares sold. Shares were sold in a range between $24.75 and $25.00 per share."}],"balance_after":199764,"source":{"system":"sec-edgar","filing":"0001161697-25-000179","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000179/form4.xml","form_type":"4"}},{"id":1258992,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-02-19T22:00:33.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Derivative securities vested in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The final tranche of shares was delivered on February 14, 2025."}],"balance_after":2234753,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001161697-25-000064","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000064/form4.xml","form_type":"4"}},{"id":1258991,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-02-19T22:00:33.000Z","date":"2025-02-14","kind":"tax_withholding","planned":false,"acquired":false,"shares":1574,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":269764,"source":{"system":"sec-edgar","filing":"0001161697-25-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000064/form4.xml","form_type":"4"}},{"id":1258990,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-02-19T22:00:33.000Z","date":"2025-02-14","kind":"exercise","planned":false,"acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":271338,"source":{"system":"sec-edgar","filing":"0001161697-25-000064","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000064/form4.xml","form_type":"4"}},{"id":1313879,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2025-01-03T22:00:13.000Z","date":"2025-01-02","kind":"exercise","planned":false,"acquired":false,"shares":42105,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Derivative securities vest in equal tranches, 1/5th each on January 1, 2025, 2026, 2027, 2028 and 2029."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on January 2, 2025."}],"balance_after":2238753,"derivative":{"underlying":"Common Stock","underlying_shares":42105},"source":{"system":"sec-edgar","filing":"0001161697-25-000025","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000025/form4.xml","form_type":"4"}},{"id":1313878,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-01-03T22:00:13.000Z","date":"2025-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":10600,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":267338,"source":{"system":"sec-edgar","filing":"0001161697-25-000025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000025/form4.xml","form_type":"4"}},{"id":1313877,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2025-01-03T22:00:13.000Z","date":"2025-01-02","kind":"exercise","planned":false,"acquired":true,"shares":42105,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":277938,"source":{"system":"sec-edgar","filing":"0001161697-25-000025","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169725000025/form4.xml","form_type":"4"}},{"id":1319684,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-12-31T21:30:17.000Z","date":"2024-12-27","kind":"exercise","planned":false,"acquired":false,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on December 27, 2024."}],"balance_after":2280858,"derivative":{"underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001161697-24-000536","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169724000536/form4.xml","form_type":"4"}},{"id":1319683,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-12-31T21:30:17.000Z","date":"2024-12-27","kind":"tax_withholding","planned":false,"acquired":false,"shares":324,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":235833,"source":{"system":"sec-edgar","filing":"0001161697-24-000536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169724000536/form4.xml","form_type":"4"}},{"id":1319682,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock, par value $0.001 per share","published_at":"2024-12-31T21:30:17.000Z","date":"2024-12-27","kind":"exercise","planned":false,"acquired":true,"shares":1333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":236157,"source":{"system":"sec-edgar","filing":"0001161697-24-000536","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169724000536/form4.xml","form_type":"4"}},{"id":1352413,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-11-25T22:00:58.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":60019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on November 21, 2025, 1/3rd on November 21, 2026 and 1/3rd on November 21, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."}],"balance_after":2282191,"derivative":{"underlying":"Common Stock","underlying_shares":60019},"source":{"system":"sec-edgar","filing":"0001161697-24-000472","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169724000472/form4.xml","form_type":"4"}},{"id":1352412,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to purchase common stock","published_at":"2024-11-25T22:00:58.000Z","date":"2024-11-21","kind":"grant","planned":false,"acquired":true,"shares":491160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on November 21, 2025, 1/3rd on November 21, 2026 and 1/3rd on November 21, 2027."}],"balance_after":2222172,"derivative":{"exercise_price":21.12,"expiration_date":"2031-11-21","underlying":"Common Stock","underlying_shares":491160},"source":{"system":"sec-edgar","filing":"0001161697-24-000472","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169724000472/form4.xml","form_type":"4"}},{"id":1489638,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to purchase common stock","published_at":"2024-06-05T21:00:50.000Z","date":"2024-06-04","kind":"exercise","planned":false,"acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vested in three annual tranches beginning on January 2, 2019."}],"balance_after":1731012,"derivative":{"exercise_price":4.01,"expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001161697-24-000254","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169724000254/form4.xml","form_type":"4"}},{"id":1489637,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock, par value $0.001 per share","published_at":"2024-06-05T21:00:50.000Z","date":"2024-06-04","kind":"sale","planned":false,"acquired":false,"shares":17323,"price":15.975,"value":276734.925,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares were sold on the open market in order to fund the exercise price and tax withholding of the exercise of the stock option."}],"balance_after":234824,"source":{"system":"sec-edgar","filing":"0001161697-24-000254","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169724000254/form4.xml","form_type":"4"}},{"id":1489636,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock, par value $0.001 per share","published_at":"2024-06-05T21:00:50.000Z","date":"2024-06-04","kind":"exercise","planned":false,"acquired":true,"shares":40000,"price":4.01,"value":160400.0,"ownership":{"direct":true},"balance_after":252147,"source":{"system":"sec-edgar","filing":"0001161697-24-000254","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169724000254/form4.xml","form_type":"4"}},{"id":1637748,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-02-16T22:01:12.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Derivative securities vest in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on February 15, 2024."}],"balance_after":1771012,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001161697-24-000097","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169724000097/form4.xml","form_type":"4"}},{"id":1637747,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock, par value $0.001 per share","published_at":"2024-02-16T22:01:12.000Z","date":"2024-02-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":1186,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Shares withheld by the Registrant to satisfy applicable withholding taxes upon vesting of restricted stock units."}],"balance_after":212147,"source":{"system":"sec-edgar","filing":"0001161697-24-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169724000097/form4.xml","form_type":"4"}},{"id":1637746,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common stock, par value $0.001 per share","published_at":"2024-02-16T22:01:12.000Z","date":"2024-02-15","kind":"exercise","planned":false,"acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":213333,"source":{"system":"sec-edgar","filing":"0001161697-24-000097","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169724000097/form4.xml","form_type":"4"}},{"id":1691309,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Restricted Stock Units","published_at":"2024-01-03T22:18:53.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":210526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in five equal annual tranches beginning on January 1, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."}],"balance_after":1775012,"derivative":{"underlying":"Common Stock","underlying_shares":210526},"source":{"system":"sec-edgar","filing":"0001161697-24-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169724000024/form4.xml","form_type":"4"}},{"id":1691308,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Options to purchase common stock","published_at":"2024-01-03T22:18:53.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":1365319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Price of derivative security is based upon the date on which the Reporting Person's executed their offer letter (dated October 18, 2023) with the Registrant, in accordance with the Registrant's 2018 Stock Incentive Plan. Mr. Daly became the Registrant's President and Chief Executive Officer on January 1, 2024 and remains a member of the Registrant's Board of Directors."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in five equal annual tranches beginning on January 1, 2025."}],"balance_after":1564486,"derivative":{"exercise_price":13.3,"expiration_date":"2031-01-01","underlying":"Common Stock","underlying_shares":1365319},"source":{"system":"sec-edgar","filing":"0001161697-24-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169724000024/form4.xml","form_type":"4"}},{"id":1697783,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-12-29T22:00:19.000Z","date":"2023-12-27","kind":"exercise","planned":false,"acquired":false,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 27, 2023."}],"balance_after":199167,"derivative":{"underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001161697-23-000642","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169723000642/form4.xml","form_type":"4"}},{"id":1697782,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-12-29T22:00:19.000Z","date":"2023-12-27","kind":"exercise","planned":false,"acquired":true,"shares":1333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":209333,"source":{"system":"sec-edgar","filing":"0001161697-23-000642","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169723000642/form4.xml","form_type":"4"}},{"id":1716080,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2023-12-11T22:00:47.000Z","date":"2023-12-07","kind":"exercise","planned":false,"acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on January 3, 2017 and previously vested in three annual installments."}],"balance_after":200500,"derivative":{"exercise_price":1.13,"expiration_date":"2017-01-03","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001161697-23-000590","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169723000590/form4.xml","form_type":"4"}},{"id":1716079,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-12-11T22:00:47.000Z","date":"2023-12-07","kind":"exercise","planned":false,"acquired":true,"shares":60000,"price":1.13,"value":67800.0,"ownership":{"direct":true},"balance_after":208000,"source":{"system":"sec-edgar","filing":"0001161697-23-000590","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169723000590/form4.xml","form_type":"4"}},{"id":1891099,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2023-05-16T21:01:48.000Z","date":"2023-05-12","kind":"exercise","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 15, 2016 and previously vested in two annual installments."}],"balance_after":260500,"derivative":{"exercise_price":0.79,"expiration_date":"2023-06-15","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001161697-23-000293","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169723000293/form4.xml","form_type":"4"}},{"id":1891098,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-05-16T21:01:48.000Z","date":"2023-05-12","kind":"exercise","planned":false,"acquired":true,"shares":50000,"price":0.79,"value":39500.0,"ownership":{"direct":true},"balance_after":148000,"source":{"system":"sec-edgar","filing":"0001161697-23-000293","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169723000293/form4.xml","form_type":"4"}},{"id":1972191,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T09:20:53.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The option was cancelled pursuant to the Merger Agreement in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was cancelled pursuant to the Merger Agreement in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."}],"balance_after":0,"derivative":{"exercise_price":8.79,"exercise_date":"2021-06-15","expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001385508-23-000071","document":"wf-form4_167785323994742.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1385508/000138550823000071/wf-form4_167785323994742.xml","form_type":"4"}},{"id":1972190,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-03T09:20:53.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The option was cancelled pursuant to the Merger Agreement in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was cancelled pursuant to the Merger Agreement in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."}],"balance_after":0,"derivative":{"exercise_price":15.56,"expiration_date":"2028-06-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001385508-23-000071","document":"wf-form4_167785323994742.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1385508/000138550823000071/wf-form4_167785323994742.xml","form_type":"4"}},{"id":1972189,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-03T09:20:53.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The option was cancelled pursuant to the Merger Agreement in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was cancelled pursuant to the Merger Agreement in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."}],"balance_after":0,"derivative":{"exercise_price":13.3,"exercise_date":"2022-06-15","expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001385508-23-000071","document":"wf-form4_167785323994742.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1385508/000138550823000071/wf-form4_167785323994742.xml","form_type":"4"}},{"id":1972188,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-03-03T09:20:53.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The option was cancelled pursuant to the Merger Agreement in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option was cancelled pursuant to the Merger Agreement in exchange for a cash payment equal to (x) the difference between the Merger Consideration and the per share exercise price of the option, multiplied by (y) the number of disposed option shares."}],"balance_after":0,"derivative":{"exercise_price":12.75,"exercise_date":"2020-06-12","expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001385508-23-000071","document":"wf-form4_167785323994742.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1385508/000138550823000071/wf-form4_167785323994742.xml","form_type":"4"}},{"id":1972187,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T09:20:53.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":2000,"price":20,"value":40000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Disposed of pursuant to the Merger Agreement in exchange for the Merger Consideration. The number of shares disposed of reflects 2,000 shares of Common Stock upon the acceleration of vesting of restricted stock units in accordance with the Merger Agreement."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001385508-23-000071","document":"wf-form4_167785323994742.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385508/000138550823000071/wf-form4_167785323994742.xml","form_type":"4"}},{"id":1972186,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T09:20:53.000Z","date":"2023-03-02","kind":"disposition_to_issuer","acquired":false,"shares":5800,"price":20,"value":116000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Disposed of pursuant to that certain Agreement and Plan of Merger between the Issuer, Indivior Inc., and Olive Acquisition Subsidiary, Inc., dated as of November 13, 2022 (the \"Merger Agreement\"), in exchange for a cash payment of $20.00 per share without interest thereon (the \"Merger Consideration\")."}],"balance_after":2000,"source":{"system":"sec-edgar","filing":"0001385508-23-000071","document":"wf-form4_167785323994742.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385508/000138550823000071/wf-form4_167785323994742.xml","form_type":"4"}},{"id":2006794,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2023-02-17T22:00:33.000Z","date":"2023-02-15","kind":"exercise","acquired":false,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on February 15, 2023."}],"balance_after":310500,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001161697-23-000124","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169723000124/form4.xml","form_type":"4"}},{"id":2006793,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2023-02-17T22:00:33.000Z","date":"2023-02-15","kind":"exercise","acquired":true,"shares":4000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":98000,"source":{"system":"sec-edgar","filing":"0001161697-23-000124","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169723000124/form4.xml","form_type":"4"}},{"id":2074819,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-12-29T21:45:39.000Z","date":"2022-12-27","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."}],"balance_after":314500,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001161697-22-000601","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169722000601/form4.xml","form_type":"4"}},{"id":2074818,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2022-12-29T21:45:39.000Z","date":"2022-12-27","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 27, 2023, 1/3rd on December 27, 2024 and 1/3rd on December 27, 2025."}],"balance_after":310500,"derivative":{"exercise_price":18.59,"expiration_date":"2029-12-27","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001161697-22-000601","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169722000601/form4.xml","form_type":"4"}},{"id":2092008,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-12-08T22:01:07.000Z","date":"2022-12-06","kind":"exercise","acquired":false,"shares":1334,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vested in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The final tranche of shares was delivered on December 6, 2022."}],"balance_after":295500,"derivative":{"underlying":"Common Stock","underlying_shares":1334},"source":{"system":"sec-edgar","filing":"0001161697-22-000570","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169722000570/form4.xml","form_type":"4"}},{"id":2092007,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2022-12-08T22:01:07.000Z","date":"2022-12-06","kind":"exercise","acquired":true,"shares":1334,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":94000,"source":{"system":"sec-edgar","filing":"0001161697-22-000570","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169722000570/form4.xml","form_type":"4"}},{"id":2172685,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2022-08-26T21:01:25.000Z","date":"2022-08-24","kind":"exercise","acquired":false,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on December 30, 2015 and previously vested in two annual installments."}],"balance_after":296834,"derivative":{"exercise_price":2.53,"expiration_date":"2022-12-30","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001161697-22-000415","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169722000415/form4.xml","form_type":"4"}},{"id":2172684,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2022-08-26T21:01:25.000Z","date":"2022-08-24","kind":"exercise","acquired":true,"shares":40000,"price":2.53,"value":101200.0,"ownership":{"direct":true},"balance_after":92666,"source":{"system":"sec-edgar","filing":"0001161697-22-000415","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169722000415/form4.xml","form_type":"4"}},{"id":2232316,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-14T16:58:13.000Z","date":"2022-06-14","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"2,000 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2023 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through each such date."},{"field":"shares","element":"transactionShares","label":"F1","text":"2,000 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2023 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through each such date."}],"balance_after":7800,"source":{"system":"sec-edgar","filing":"0001385508-22-000088","document":"wf-form4_165524027803629.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385508/000138550822000088/wf-form4_165524027803629.xml","form_type":"4"}},{"id":2391380,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2022-02-16T22:01:52.000Z","date":"2022-02-14","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on February 14, 2023, 1/3rd on February 14, 2024 and 1/3rd on February 14, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person within sixty (60) days of vesting."}],"balance_after":336834,"derivative":{"underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001161697-22-000111","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169722000111/form4.xml","form_type":"4"}},{"id":2425010,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2022-01-26T22:29:17.000Z","date":"2022-01-25","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vested in three equal tranches beginning on February 19, 2016."}],"balance_after":324834,"derivative":{"exercise_price":3.35,"expiration_date":"2022-02-19","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001161697-22-000071","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169722000071/form4.xml","form_type":"4"}},{"id":2425009,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common stock, par value $0.001 per share","published_at":"2022-01-26T22:29:17.000Z","date":"2022-01-25","kind":"exercise","acquired":true,"shares":50000,"price":3.35,"value":167500.0,"ownership":{"direct":true},"balance_after":52666,"source":{"system":"sec-edgar","filing":"0001161697-22-000071","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169722000071/form4.xml","form_type":"4"}},{"id":2456119,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-12-30T21:46:02.000Z","date":"2021-12-28","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 28, 2022, 1/3rd on December 28, 2023 and 1/3rd on December 28, 2024."}],"balance_after":374834,"derivative":{"exercise_price":7.07,"expiration_date":"2028-12-28","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001161697-21-000611","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169721000611/form4.xml","form_type":"4"}},{"id":2483489,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2021-12-06T22:10:22.000Z","date":"2021-12-03","kind":"exercise","acquired":false,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock are required to be delivered to the Reporting Person within sixty days of vesting. The second tranche of shares was delivered on December 3, 2021."}],"balance_after":354834,"derivative":{"underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001161697-21-000551","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169721000551/form4.xml","form_type":"4"}},{"id":2483488,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2021-12-06T22:10:22.000Z","date":"2021-12-03","kind":"exercise","acquired":true,"shares":1333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":2666,"source":{"system":"sec-edgar","filing":"0001161697-21-000551","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169721000551/form4.xml","form_type":"4"}},{"id":2665735,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-16T16:07:00.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 15, 2021, the reporting person was granted 2,500 non-qualified stock options. 100% of the options vest on the one year anniversary of the grant date or the date of the 2022 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":2500,"derivative":{"exercise_price":13.3,"exercise_date":"2022-06-15","expiration_date":"2031-06-14","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001385508-21-000087","document":"wf-form4_162387400674324.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385508/000138550821000087/wf-form4_162387400674324.xml","form_type":"4"}},{"id":2665734,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-16T16:07:00.000Z","date":"2021-06-15","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"2,000 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2022 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":5800,"source":{"system":"sec-edgar","filing":"0001385508-21-000087","document":"wf-form4_162387400674324.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385508/000138550821000087/wf-form4_162387400674324.xml","form_type":"4"}},{"id":2925126,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2021-01-04T21:32:00.000Z","date":"2020-12-30","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 30, 2021, 1/3rd on December 30, 2022 and 1/3rd on December 30, 2023."}],"balance_after":356167,"derivative":{"exercise_price":3.42,"expiration_date":"2027-12-30","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001161697-21-000007","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169721000007/form4.xml","form_type":"4"}},{"id":2930994,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2020-12-28T21:35:11.000Z","date":"2020-12-22","kind":"exercise","acquired":false,"shares":1333,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person within sixty days of vesting. The first tranche of shares was delivered on December 22, 2020."}],"balance_after":326167,"derivative":{"underlying":"Common Stock","underlying_shares":1333},"source":{"system":"sec-edgar","filing":"0001161697-20-000598","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169720000598/form4.xml","form_type":"4"}},{"id":2930993,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, par value $0.001 per share","published_at":"2020-12-28T21:35:11.000Z","date":"2020-12-22","kind":"exercise","acquired":true,"shares":1333,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."}],"balance_after":1333,"source":{"system":"sec-edgar","filing":"0001161697-20-000598","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169720000598/form4.xml","form_type":"4"}},{"id":3110163,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T16:16:24.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"On June 15, 2020, the Reporting Person was granted 2,500 non-qualified stock options. 100% of the options vest on the one year anniversary of the grant date or the date of the 2021 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 15, 2020, the Reporting Person was granted 2,500 non-qualified stock options. 100% of the options vest on the one year anniversary of the grant date or the date of the 2021 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through such date."}],"balance_after":2500,"derivative":{"exercise_price":8.79,"exercise_date":"2021-06-15","expiration_date":"2030-06-15","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001385508-20-000079","document":"wf-form4_159225216729096.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385508/000138550820000079/wf-form4_159225216729096.xml","form_type":"4"}},{"id":3110162,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-15T16:16:24.000Z","date":"2020-06-15","kind":"grant","acquired":true,"shares":2000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"2,000 shares are represented by restricted stock units (\"RSUs\"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of Issuer, subject to the vesting schedule: 100% vest on the one year anniversary date or the date of the 2021 Annual Shareholder Meeting, whichever is earlier, subject to the Reporting Person continuing as a service provider through each date."}],"balance_after":3800,"source":{"system":"sec-edgar","filing":"0001385508-20-000079","document":"wf-form4_159225216729096.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385508/000138550820000079/wf-form4_159225216729096.xml","form_type":"4"}},{"id":3237456,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-03-02T16:04:06.000Z","date":"2019-09-12","kind":"purchase","acquired":true,"shares":1800,"price":13.9,"value":25020.0,"ownership":{"direct":true},"balance_after":1800,"source":{"system":"sec-edgar","filing":"0001385508-20-000030","document":"wf-form4_158318302808179.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385508/000138550820000030/wf-form4_158318302808179.xml","form_type":"4"}},{"id":3352278,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2019-12-04T22:27:47.000Z","date":"2019-12-02","kind":"grant","acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Registrant's common stock upon vesting."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Shares of common stock will be delivered to the Reporting Person upon vesting."}],"balance_after":327500,"derivative":{"underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001161697-19-000528","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169719000528/form4.xml","form_type":"4"}},{"id":3352277,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2019-12-04T22:27:47.000Z","date":"2019-12-02","kind":"grant","acquired":true,"shares":33500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Derivative securities vest in equal tranches, 1/3rd on December 2, 2020, 1/3rd on December 2, 2021 and 1/3rd on December 2, 2022."}],"balance_after":323500,"derivative":{"exercise_price":4.64,"expiration_date":"2026-12-02","underlying":"Common Stock","underlying_shares":33500},"source":{"system":"sec-edgar","filing":"0001161697-19-000528","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169719000528/form4.xml","form_type":"4"}},{"id":3491172,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-13T16:11:11.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":2500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 12, 2019, the reporting person was granted 2,500 non-qualified stock options. 100% of the options vest on the one year anniversary of the grant date."}],"balance_after":2500,"derivative":{"exercise_price":12.75,"exercise_date":"2020-06-12","expiration_date":"2029-06-11","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001385508-19-000065","document":"wf-form4_156045665674490.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385508/000138550819000065/wf-form4_156045665674490.xml","form_type":"4"}},{"id":3720749,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-12-21T21:48:02.000Z","date":"2018-12-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":290000,"derivative":{"exercise_price":2.24,"exercise_date":"2019-12-19","expiration_date":"2025-12-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001161697-18-000626","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169718000626/form4.xml","form_type":"4"}},{"id":3720748,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-12-21T21:48:02.000Z","date":"2018-12-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":265000,"derivative":{"exercise_price":2.24,"exercise_date":"2018-12-19","expiration_date":"2025-12-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001161697-18-000626","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169718000626/form4.xml","form_type":"4"}},{"id":3895099,"issuer":{"id":115992,"kind":"organization","name":"OPIANT PHARMACEUTICALS, INC.","symbol":"OPNT"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-13T16:07:23.000Z","date":"2018-06-12","kind":"grant","acquired":true,"shares":5000,"price":15.56,"value":77800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On June 12, 2018, the reporting person was granted an option to purchase 5,000 shares of common stock. The options vest as follows: 33% of the options vest on the first, second and third anniversary of the grant date."}],"balance_after":5000,"derivative":{"exercise_price":15.56,"expiration_date":"2028-06-11","underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001385508-18-000057","document":"wf-form4_152892042492264.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385508/000138550818000057/wf-form4_152892042492264.xml","form_type":"4"}},{"id":4106799,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-01-04T21:47:33.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":240000,"derivative":{"exercise_price":4.01,"exercise_date":"2019-01-02","expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001161697-18-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169718000024/form4.xml","form_type":"4"}},{"id":4106798,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2018-01-04T21:47:33.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":220000,"derivative":{"exercise_price":4.01,"exercise_date":"2018-01-02","expiration_date":"2025-01-02","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001161697-18-000024","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169718000024/form4.xml","form_type":"4"}},{"id":4167581,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock Purchase Option","published_at":"2017-11-09T21:00:44.000Z","date":"2017-11-07","kind":"grant","acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents a discretionary grant to Employee. The options vest quarterly on 2/718, 5/7/18, 8/7/18, and 11/7/18."}],"balance_after":100000,"derivative":{"exercise_price":1.12,"exercise_date":"2017-11-07","expiration_date":"2027-11-07","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001171843-17-006832","document":"formfour.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184317006832/formfour.xml","form_type":"4"}},{"id":4268992,"issuer":{"id":164269,"kind":"organization","name":"SYNERGY PHARMACEUTICALS, INC.","symbol":"SGYP"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options","published_at":"2017-06-30T17:09:52.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":189056,"derivative":{"exercise_price":4.5,"exercise_date":"2018-06-28","expiration_date":"2027-06-28","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001104659-17-043016","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1347613/000110465917043016/a4.xml","form_type":"4"}},{"id":4313415,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-05-18T17:02:20.000Z","date":"2017-05-17","kind":"purchase","acquired":true,"shares":7500,"price":4,"value":30000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reporting person, Richard Daly, purchased 7,500 shares of common stock in a private transaction directly from the issuer on May 17, 2017."}],"balance_after":23312,"source":{"system":"sec-edgar","filing":"0001171843-17-003169","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184317003169/formfour.xml","form_type":"4"}},{"id":4421189,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-02-27T21:30:16.000Z","date":"2017-02-24","kind":"purchase","acquired":true,"shares":2591,"price":3.86,"value":10001.26,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reporting person, Richard Daly, purchased 2,591 shares of common stock in a private transaction directly from the issuer."}],"balance_after":15812,"source":{"system":"sec-edgar","filing":"0001171843-17-001161","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184317001161/form4.xml","form_type":"4"}},{"id":4479092,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2017-01-27T21:18:34.000Z","date":"2017-01-25","kind":"purchase","acquired":true,"shares":2841,"price":3.52,"value":10000.32,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reporting person, Richard Daly, purchased 2,841 shares of common stock in a private transaction directly from the issuer."}],"balance_after":13221,"source":{"system":"sec-edgar","filing":"0001171843-17-000498","document":"form4daly.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184317000498/form4daly.xml","form_type":"4"}},{"id":4497915,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2017-01-05T22:06:03.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":200000,"derivative":{"exercise_price":1.13,"exercise_date":"2018-01-03","expiration_date":"2024-01-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001161697-17-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169717000008/form4.xml","form_type":"4"}},{"id":4497914,"issuer":{"id":29708,"kind":"organization","name":"CATALYST PHARMACEUTICALS, INC.","symbol":"CPRX"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Options to purchase common stock","published_at":"2017-01-05T22:06:03.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":170000,"derivative":{"exercise_price":1.13,"exercise_date":"2017-01-03","expiration_date":"2024-01-03","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001161697-17-000008","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1369568/000116169717000008/form4.xml","form_type":"4"}},{"id":4509683,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-12-30T21:05:14.000Z","date":"2016-12-23","kind":"purchase","acquired":true,"shares":32259,"price":0.31,"value":10000.29,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reporting person, Richard Daly, purchased 32,259 shares of common stock in a private transaction directly from the issuer."}],"balance_after":134939,"source":{"system":"sec-edgar","filing":"0001171843-16-013813","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184316013813/formfour.xml","form_type":"4"}},{"id":4541103,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-11-28T22:36:01.000Z","date":"2016-11-25","kind":"purchase","acquired":true,"shares":35715,"price":0.28,"value":10000.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reporting person, Richard Daly, purchased 35,715 shares of common stock in a private transaction directly from the issuer."}],"balance_after":102680,"source":{"system":"sec-edgar","filing":"0001171843-16-013393","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184316013393/formfour.xml","form_type":"4"}},{"id":4573449,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-10-27T20:05:14.000Z","date":"2016-10-25","kind":"purchase","acquired":true,"shares":35715,"price":0.28,"value":10000.2,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reporting person, Richard Daly, purchased 35,715 shares of common stock in a private transaction directly from the issuer."}],"balance_after":66965,"source":{"system":"sec-edgar","filing":"0001171843-16-012678","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184316012678/formfour.xml","form_type":"4"}},{"id":4595002,"issuer":{"id":5803,"kind":"organization","name":"PALISADE BIO, INC.","symbol":"PALI"},"owners":[{"id":29712,"kind":"person","name":"Daly Richard J","position":1,"cik":"0001635393","reported_name":"Daly Richard J","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2016-09-26T20:50:55.000Z","date":"2016-09-23","kind":"purchase","acquired":true,"shares":31250,"price":0.32,"value":10000.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Reporting person, Richard Daly, purchased 31,250 shares of common stock in a private transaction directly from the issuer."}],"balance_after":31250,"source":{"system":"sec-edgar","filing":"0001171843-16-012274","document":"f4_092616daly.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1357459/000117184316012274/f4_092616daly.xml","form_type":"4"}}]}